Vamicamide

Vamicamide

SCHEMBL9393264

CC(CC(C(N)=O)(c1ccccc1)c1ccccn1)N(C)C

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 4/20 0.65
▸ OPRK1 P41145 2/20 0.65
▸ BLM P54132 2/20 0.65
▸ SLC22A2 O15244 1/20 0.65
▸ SLC22A1 O15245 1/20 0.65
▸ PGR P06401 1/20 0.65
▸ THRB P10828 1/20 0.65
▸ ADRB3 P13945 1/20 0.65
▸ PMP22 Q01453 1/20 0.65
▸ PDE3A Q14432 1/20 0.65
▸ SLC47A1 Q96FL8 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ ALOX15 P16050 1/20 0.65
▸ TSHR P16473 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65
▸ GRIN1 Q05586 6/20 0.60
▸ GRIN2A Q12879 6/20 0.60
▸ GRIN2D O15399 5/20 0.60
▸ GRIN2C Q14957 5/20 0.60
▸ GRIN2B Q13224 4/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vamicamide SCHEMBL30700593 1.00 KCNH2 (0.65) KCNH2OPRK1BLMSLC22A2SLC22A1
Vamicamide SCHEMBL331820 1.00 KCNH2 (0.65) KCNH2OPRK1BLMSLC22A2SLC22A1
Vamicamide SCHEMBL9393357 0.99 KCNH2 (0.64) KCNH2OPRK1BLMSLC22A2SLC22A1
Vamicamide SCHEMBL4603765 0.99 KCNH2 (0.64) KCNH2OPRK1BLMSLC22A2SLC22A1
Aminopentamide Sulfate SCHEMBL251458 0.85 GRIN1 (0.75) KCNH2OPRK1BLMSLC22A2SLC22A1
Aminopentamide Sulfate SCHEMBL203612 0.80 GRIN1 (0.68) KCNH2OPRK1BLMSLC22A2SLC22A1
Disopyramide SCHEMBL23931452 0.79 KCNH2 (1.00) KCNH2OPRK1BLMSLC22A2SLC22A1
(S)-Disopyramide SCHEMBL41811 0.79 KCNH2 (1.00) KCNH2OPRK1BLMSLC22A2SLC22A1
Disopyramide SCHEMBL16153 0.79 KCNH2 (1.00) KCNH2OPRK1BLMSLC22A2SLC22A1
Disopyramide SCHEMBL546251 0.78 KCNH2 (0.98) KCNH2OPRK1BLMSLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452809-B1 A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-27 — — EP claimed
EP-0452809-A2 A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-10-23 — — EP claimed
EP-0105458-B1 ALPHA-ARYL-ALPHA-PYRIDYLALKANOIC ACID DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-11-23 — — EP claimed
US-4564621-A ANTIULCER AND ANTISPASMODIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-14 — — US claimed
JP-60069017-A — — None — — JP disclosed
JP-59080664-A — — None — — JP disclosed
EP-0452809-B1 A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1994-07-27 — — EP disclosed
EP-0452809-A2 A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-10-23 — — EP disclosed
EP-0105458-B1 ALPHA-ARYL-ALPHA-PYRIDYLALKANOIC ACID DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-11-23 — — EP disclosed
US-4564621-A ANTIULCER AND ANTISPASMODIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-14 — — US disclosed
JP-S6069017-A ANTISPASMODIC FUJISAWA PHARMACEUT CO LTD 1985-04-19 — — JP disclosed
JP-S5980664-A ALPHA-ARYL-ALPHA-PYRIDYLFATTY ACID DERIVATIVE AND PREPARATION THEREOF FUJISAWA PHARMACEUT CO LTD 1984-05-10 — — JP disclosed
Send feedback